Regenerative Medicine For Cartilage Market Report 2023-2032: Market Size, Key Drivers And Industry Forecast
The Business Research Company's Regenerative Medicine For Cartilage Global Market Report 2023 identifies growing incidence of osteoarthritis across the globe as the major driver for the Regenerative Medicine For Cartilage market's growth in the forecast period. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050.
The global regenerative medicine for cartilage market size grew from $5.28 billion in 2022 to $5.82 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%. The regenerative medicine for cartilage market size is expected to grow to $7.72 billion in 2027 at a CAGR of 7.3%.
A key trend in the Regenerative Medicine For Cartilage market includes Tissue engineering and stem cell therapy. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopaedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair. growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively.
https://www.openpr.com/news/3194873/regenerative-medicine-for-cartilage-market-report-2023-2032
ارسال به دوستان